Institutional Ownership Adagio Therapeutics, Inc. (ADGI)
This table provides information about the institutional ownership of Adagio Therapeutics, Inc. (ADGI). We have compiled data on the 82 institutions that hold shares in the stock, with a total of 67.8 Million shares, which have been reported (via 13F filing form) to have a value of $224 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Mithril Ii Gp LP
Austin, TX |
May 09, 2025 Q1 2025 |
11,241,580
shares
|
$37.2 Million
46.08% of portfolio
|
Q4 2024
New holding
|
|
|
Lee Ainslie
Maverick Capital LTD | Dallas, Tx
|
May 15, 2025 Q1 2025 |
10,958,572
shares
|
$36.3 Million
0.71% of portfolio
|
Q1 2025
Reduced 6.86%
|
|
|
Deep Track Capital, LP
Greenwich, CT |
May 15, 2025 Q1 2025 |
9,722,254
shares
|
$32.2 Million
1.13% of portfolio
|
Q1 2025
Reduced 9.05%
|
|
|
M28 Capital Management LP
Stamford, CT |
May 14, 2025 Q1 2025 |
9,248,250
shares
|
$30.6 Million
32.33% of portfolio
|
Q3 2022
Added 44.54%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
4,473,808
shares
|
$14.8 Million
0.0% of portfolio
|
Q2 2024
Added 410.38%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
May 09, 2025 Q1 2025 |
4,396,990
shares
|
$14.6 Million
0.0% of portfolio
|
Q1 2025
Added 1.32%
|
|
|
683 Capital Management, LLC
New York, NY |
May 15, 2025 Q1 2025 |
3,000,000
shares
|
$9.93 Million
0.8% of portfolio
|
Q3 2024
Reduced 17.24%
|
|
|
Redmile Group, LLC
San Francisco, CA |
May 15, 2025 Q1 2025 |
2,285,320
shares
|
$7.56 Million
0.79% of portfolio
|
Q1 2025
Reduced 24.13%
|
|
|
Bain Capital Life Sciences Investors, LLC
Boston, MA |
May 15, 2025 Q1 2025 |
1,799,595
shares
|
$5.96 Million
2.0% of portfolio
|
Q1 2024
Reduced 7.1%
|
|
|
Geode Capital Management, LLC
Boston, MA |
May 13, 2025 Q1 2025 |
1,625,654
shares
|
$5.38 Million
0.0% of portfolio
|
Q1 2025
Added 1.75%
|
|
|
State Street Corp
Boston, MA |
May 15, 2025 Q1 2025 |
997,133
shares
|
$3.3 Million
0.0% of portfolio
|
Q1 2025
Reduced 12.97%
|
|
|
Orbimed Advisors LLC
San Diego, CA |
May 15, 2025 Q1 2025 |
933,500
shares
|
$3.09 Million
0.1% of portfolio
|
Q1 2025
Reduced 18.78%
|
|
|
Morgan Stanley
New York, NY |
May 15, 2025 Q1 2025 |
741,122
shares
|
$2.45 Million
0.0% of portfolio
|
Q1 2025
Added 268.82%
|
|
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
May 09, 2025 Q1 2025 |
655,278
shares
|
$2.17 Million
0.0% of portfolio
|
Q1 2025
Reduced 25.06%
|
|
|
Northern Trust Corp
Chicago, IL |
May 13, 2025 Q1 2025 |
589,034
shares
|
$1.95 Million
0.0% of portfolio
|
Q1 2025
Added 5.45%
|
|
|
Stanley Druckenmiller
Duquesne Family Office LLC | New York, Ny
|
May 15, 2025 Q1 2025 |
571,425
shares
|
$1.89 Million
0.01% of portfolio
|
Q2 2024
New holding
|
|
|
Acadian Asset Management LLC
Boston, MA |
Feb 11, 2025 Q4 2024 |
505,528
shares
|
$1.67 Million
0.0% of portfolio
|
Q4 2024
Reduced 22.5%
|
|
|
Ubs Group Ag
|
May 13, 2025 Q1 2025 |
440,694
shares
|
$1.46 Million
0.0% of portfolio
|
Q1 2025
Added 13.77%
|
|
|
Aqr Capital Management LLC
Greenwich, CT |
May 15, 2025 Q1 2025 |
410,711
shares
|
$1.36 Million
0.0% of portfolio
|
Q1 2025
Added 2051.0%
|
|
|
Tang Capital Management LLC
San Diego, CA |
May 15, 2025 Q1 2025 |
400,000
shares
|
$1.32 Million
0.09% of portfolio
|
Q1 2025
Added 21.15%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
May 15, 2025 Q1 2025 |
260,686
shares
|
$862,870
0.0% of portfolio
|
Q1 2025
Added 297.73%
|
|
|
Goldman Sachs Group Inc
New York, NY |
May 16, 2025 Q1 2025 |
255,970
shares
|
$847,260
0.0% of portfolio
|
Q1 2025
Added 2.33%
|
|
|
Two Sigma Investments, LP
New York, NY |
May 15, 2025 Q1 2025 |
240,607
shares
|
$796,409
0.0% of portfolio
|
Q1 2025
Reduced 34.46%
|
|
|
Gsa Capital Partners LLP
London, X0 |
May 08, 2025 Q1 2025 |
192,660
shares
|
$637,704
0.01% of portfolio
|
Q1 2025
Reduced 58.34%
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
May 09, 2025 Q1 2025 |
186,680
shares
|
$617,910
0.0% of portfolio
|
Q4 2024
Reduced 11.42%
|